Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin, Tranexamic Acid, and Ergot Derivative vs Carbetocin for PPH Prevention in C-Section
NCT07318467Not yet recruiting
- Sponsor
- Cairo University
- Start
- Jan 2026
- Primary completion
- Jun 2026
- Modality
- Peptides, Small Molecules
01
Overview
Trial of oxytocin, tranexamic acid and methylergometrine in postpartum hemorrhage (PPH) (2 arms), sponsored by Cairo University. Primary endpoint: Amount of blood loss. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
oxytocintranexamic acidmethylergometrine
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on NCT07318467.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07318467.